Some statistical considerations on the FDA draft guidance for individual bioequivalence
Author:
- 6 October 2000
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 19 (20) , 2879-2884
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Individual and Average Bioequivalence of Highly Variable Drugs and Drug ProductsJournal of Pharmaceutical Sciences, 1997
- Individual BioequivalenceClinical Pharmacokinetics, 1997
- Individual bioequivalence—a european perspectiveJournal of Biopharmaceutical Statistics, 1997
- Discussion of individual bioequivalence by M.-L. chenJournal of Biopharmaceutical Statistics, 1997
- Individual bioequivalence—a regulatory updateJournal of Biopharmaceutical Statistics, 1997
- Towards a practical strategy for assessing individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1996
- Moment-based criteria for determining bioequivalenceBiometrika, 1993
- On population and individual bioequivalenceStatistics in Medicine, 1993
- Bioequivalence revisitedStatistics in Medicine, 1992
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990